Funding
ABUSE
The study is supported by the National Institutes of Health HEAL Initiative and the National Institute on Drug Abuse (NIDA) Center for Clinical Trials Network (CTN) grant for CTN 0101 as well as the following awards to CTN Sites by NIDA: Appalachian Node (UG1DA049436), New York Node (UG1DA013035), Western States Node (UG1DA015815), Mid Southern (Node UG1DA040317) and Southern California Node (UG1DA049435). The Emmes Clinical Coordinating Center was funded by Contract No. 75N95020D00012 for August 2020 to August 2025 and Contract No. HHSN271201500065C for August 2015 to August 2020. Amanda Bunting, PhD was supported by AHRQ T32 HS026120. The Emmes Data and Statistics Center was funded by Contract No. 75N95019D00013. The funders has no direct role in the conduct of the trial other than the participation of the Scientific Officer (Dr. Subramamiam) consistent with the role within NIDA clinical trials network.